ICC Labs Obtains Final Order For Arrangement With Aurora Cannabis VANCOUVER, British Columbia, Nov. 08, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC) (TSX-V: ICC) is pleased to announce that the Supreme Court of British Columbia has issued a final order (the Final Order) approving the plan of arrangement (the Arrangement) between ICC and Aurora Cannabis Inc. (Aurora) (TSX: ACB, NYSE: ACB). Subject to the terms and conditions of an arrangement agreement between ICC and Aurora dated September 8, 2018 (the Arrangement Agreement), Aurora will acquire all of the issued and outsta...
ICC Labs Announces Shareholder Approval of Arrangement With Aurora Cannabis VANCOUVER, British Columbia, Nov. 06, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC) (TSX-V: ICC) is pleased to announce that, at the special meeting of shareholders of ICC (ICC Shareholders) held today (the Meeting), ICC Shareholders overwhelmingly voted in favour of a special resolution (the Arrangement Resolution) to approve the previously announced plan of arrangement (the Arrangement) between ICC and Aurora Cannabis Inc. (Aurora) (TSX: ACB, NYSE: ACB). Subject to the terms and conditions of an ar...
Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition of ICC Milestone towards Completing Transaction to Establish Leadership in South American Market EDMONTON, Alberta and VANCOUVER, British Columbia, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (Aurora) (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) and ICC Labs Inc. (ICC) (TSX-V: ICC) are pleased to announce that Aurora has received, from its consortium of lenders led by Bank of Montreal (collectively, the Lenders), consent and approval as required under its credit agreement with the Lenders to the previou...
ICC Labs Provides Information About Circular VANCOUVER, British Columbia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (ICC or the Company) (TSX-V: ICC) confirms that the management information circular dated October 3, 2018 (the Circular), form of proxy and other materials with respect to the Company’s proposed plan of arrangement (the Arrangement) with Aurora Cannabis Inc. (Aurora) have been mailed to holders (the ICC Shareholders) of common shares of ICC (the ICC Shares) of record as of September 26, 2018 in accordance with an interim order of the Supreme Court of British Columbia. ...
ICC Labs Obtains Interim Order for Arrangement With Aurora Cannabis VANCOUVER, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC Labs) (TSX-V: ICC) is pleased to announce that it has obtained an interim order of the Supreme Court of British Columbia authorizing, among other things, the holding of the Company’s special meeting of holders (the ICC Shareholders) of common shares (ICC Shares). At the meeting, the ICC Shareholders will be asked to consider and vote on a special resolution (the Arrangement Resolution) approving a statutory plan of arrangement...
Aurora Cannabis to Acquire South American Market Leader ICC Labs Transaction Establishes Strong Foundation for Aurora’s South American Growth Strategy in Medical, Adult Consumer Use and CBD Wellness Markets EDMONTON, Alberta and VANCOUVER, British Columbia, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (Aurora or the Company) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and ICC Labs Inc. (TSX-V: ICC) (ICC) announced today that the companies have entered into a definitive arrangement agreement pursuant to which Aurora intends to acquire all of the issued and outstand...
ICC Labs Files Financial Results for the Second Quarter Ended June 30 and Completes the Construction of Its 124,000 sq. ft. Greenhouse in Colombia to Produce Psychoactive Medicinal Cannabis VANCOUVER, British Columbia, Aug. 30, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V: ICC) is pleased to announce that it has filed its interim financial results for the second quarter ended June 30, 2018. ICC Labs is also pleased to announce that has completed the construction of its 124,000 sq. ft. greenhouse in Tabio, which is strategically located just north of Bogotá, ...
ICC Responds to Media Reports VANCOUVER, British Columbia, Aug. 23, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V: ICC) is aware of a recent Spanish language media report speculating as to a potential transaction involving the acquisition of the Company. The policy of the Company is not to comment on rumors or speculation in the marketplace or any potential transaction unless, and until, a binding legal agreement to effect that transaction has been signed. However, in response to a request from the Investment Industry Regulatory Organization of Canada, the ...
ICC Labs Receives Additional Land From the Government of Uruguay to Increase Its Production Capacity at Its Psychoactive Facility VANCOUVER, British Columbia, June 26, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V:ICC) (Frankfurt:2Q9) is pleased to announce that the Government of Uruguay through its regulatory authority IRCCA (Cannabis Regulation and Control Institute) has granted the Company an additional land package of approximately 55,000 square foot in order to increase its production capacity. “A relevant milestone that demonstrates the confidence that...
ICC Labs Completes Its First Outdoor Harvest and Prepares to Produce Its First CBD Extracts VANCOUVER, British Columbia, June 21, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V:ICC) (Frankfurt:2Q9) is pleased to announce that it has completed its first outdoor harvest of hemp. The Company harvested hemp planted on approximately 430 acres of land distributed between its Canelones and Flores sites. The Company is now commencing the drying process for the harvested material, which will take between three to four weeks, and is preparing the soil for the next seedi...
ICC Labs Announces Its First Presale Agreement in the European Market With VenPharma VANCOUVER, British Columbia, June 13, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V:ICC) (Frankfurt:2Q9) is pleased to announce that KSK Labs, a 100% subsidiary of Global Group Kalapa, of which ICC Labs recently acquired 25%, subject to TSX Venture Exchange approval, has closed a presale agreement with a Spain-based company, VenPharma, in order to distribute cannabidiol (“CBD”) products in Spanish pharmacies and drugstores. VenPharma is a laboratory specialized in natural ...
ICC Labs Announces Its First Presale Agreement of CBD/THC Extracts and CBD/THC Oils for Distribution in Colombia Highlights: ICC Labs enters into its first CBD/THC presale agreement in Colombia. Colombia is the third country in the Latin American market where ICC Labs has now taken steps to commence sales, after México and Brazil, opening up large potential markets with a total population of approximately 380 million people. Construction continues as planned for our 124,000 sq. ft. Colombian cannabis cultivation greenhouse, which is expected to be completed by the end of June 2018. VAN...
A director at ICC Labs Inc bought 45,300 shares at 1.461CAD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.